NAMS EPS Estimates
NewAmsterdam Pharma Company N.V.
$20.62
+$0.61(+3.05%)
44
Overall
50
Value
36
Tech
47
Quality
Market Cap
$2.46B
Volume
881.93K
52W Range
$20.91 - $42.21
Target Price
$51.00
NAMS EPS estimates: the consensus estimate for NewAmsterdam Pharma Company N.V.'s current fiscal year is -$1.82 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NAMS EPS Estimates
- EPS estimate, current quarter
- $-0.50
- EPS estimate, next quarter
- $-0.38
- EPS estimate, current year
- $-1.82
- EPS estimate, next year
- $-1.62
- EPS growth, 3-year
- -21.46%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.72 |
| 2024 | $-2.56 |
| 2023 | $-2.15 |
| 2022 | $-0.96 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $20.62 | +3.0% | 881.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW